BALPHARMA
Pharmaceuticals & Drugs
₹93.35
0.00 (0.00%)
Market Cap | 146 Cr | EPS | 1.5 | High | 95.1 | ||
Stock P/E | 62.1 | Net Profit Margin | 0.1 | Low | 92.2 |
Performance
Today’s Low
Today’s High
92.2
95.1
52W Low
52W High
63.35
106.5
Open Price | 93.35 | Volume | 1 |
Prev. Close | 93.35 |
Fundamentals
Market Cap | 146 Cr | ROE | 4.3% | ||
P/E Ratio(TTM) | 62.1 | EPS(TTM) | 0.0 | ||
P/B Ratio | 2.3 | Dividend Yield | 1.1% | ||
Industry P/E | 41.3 | Book Value | 40.7 | ||
Face Value | 10.0 |
About the Company
Bal Pharma Limited is a leading Indian Pharmaceutical Company with 25+ years of experience, specialized in Prescription Drugs, Generic & OTC Products, Intravenous Infusion and Bulk Actives.
The company strives hard to improve the quality of life for patients by providing them products that are Safe, Effective, High Quality and Affordable.
The company’s API and FDF are produced at world class manufacturing facilities. APIs are largely exported to Europe, Far East, Latin America, Africa, Middle East and other World markets. The FDF are exported to Semi-Regulated, Non-Regulated market and are now foraying to regulated market. The company is also one of the strong contenders for World Tender Business.
Business area of the company
The company is engaged in the manufacturing and selling of pharmaceutical products. The company caters to both domestic and international markets.
Business segments
API Intermediate: The company’s API (Active Pharmaceutical Ingredients) business began in 1996 with a simple objective of facilitating the manufacture of niche molecules that have been able to take the benefits of vertical integration to international and domestic markets. Bal Pharma’s API business has the competence and knowledge to undertake more than 30 different types of complex chemical reactions.
Finished formulations: Bal Pharma has a winning formula of cutting edge technology, handled by a highly qualified professional with a passion to deliver beyond excellence. The company is successfully exporting Finished Formulation to many countries. The company offers extensive range of products covering dosage forms - tablets, capsules, syrups, suspensions, IV infusions, Ophthalmic, creams and ointments to various Semi-Regulated markets.
Ayurveda/Herbal: Ayurveda is India’s traditional, natural system of medicine that has been practiced for more than 5,000 years. Ayurveda is a Sanskrit word that, when literally translated, means 'science of life' or 'practices of longevity.' Ayurveda provides an integrated approach to preventing and treating illness through lifestyle interventions and natural therapies. The company’s objective of providing “Good life to All” launched its Ayurvedic Division - Bal Vedics in 2003. Bal Vedics is dedicated to bringing out ‘nature’s best’ through International Quality Natural Formulations that combine traditional Indian Wisdom of medicine with Scientific Manufacturing.
Parent Organization | Bal Pharma Ltd. | Managing Director | Shailesh Siroya | ||
Founded | 1987 | NSE Symbol | BALPHARMA |
Financials
All values are in Rs Cr
Shareholding Pattern
Domestic Institutions
0.00%
Foreign Institutions
0.30%
Mutual Funds
0.00%
Promoters
52.00%
Domestic Institutions
0.00%
Foreign Institutions
0.30%
Mutual Funds
0.00%
Promoters
52.00%
Domestic Institutions
0.00%
Foreign Institutions
0.30%
Mutual Funds
0.00%
Promoters
52.00%
Domestic Institutions
0.00%
Foreign Institutions
0.30%
Mutual Funds
0.00%
Promoters
52.00%
Domestic Institutions
0.00%
Foreign Institutions
0.30%
Mutual Funds
0.00%
Promoters
52.00%
Peer Comparison
Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
---|---|---|---|---|---|
93.35(0.0%) | 62.1 | ||||
77.8(-2.4%) | 0.0 | ||||
72.35(0.2%) | 11.8 | ||||
517.35(0.6%) | 23.4 |